Gastrointestinal ulcers, role of aspirin, and clinical outcomes: pathobiology, diagnosis, and treatment

References

• MalfertheinerPChanFKMcCollKEPeptic ulcer diseaseLancet200937496991449146119683340
   PubMed Web of Science ®Google Scholar
• FeinsteinLBHolmanRCYorita ChristensenKLSteinerCASwerdlowDLTrends in hospitalizations for peptic ulcer disease, United States, 1998–2005Emerg Infect Dis20101691410141820735925
   PubMed Web of Science ®Google Scholar
• LaineLJensenDMManagement of patients with ulcer bleedingAm J Gastroenterol2012107334536022310222
   PubMed Web of Science ®Google Scholar
• HasniSIppolitoAIlleiGGHelicobacter pylori and autoimmune diseasesOral Dis201117762162721902767
   PubMed Web of Science ®Google Scholar
• CinaSJMimsWW3rdNicholsCAConradiSEFrom emergency room to morgue: deaths due to undiagnosed perforated peptic ulcers. Report of four cases with review of the literatureAm J Forensic Med Pathol199415121278166110
   PubMed Web of Science ®Google Scholar
• ArmstrongCPWhitelawSDeath from undiagnosed peptic ulcer complications: a continuing challengeBr J Surg19887511111211143208046
   PubMed Web of Science ®Google Scholar
• GriffinMRPiperJMDaughertyJRSnowdenMRayWANonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly personsAnn Intern Med199111442572631987872
   PubMed Web of Science ®Google Scholar
• GriffinMRRayWASchaffnerWNonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly personsAnn Intern Med198810953593633261560
   PubMed Web of Science ®Google Scholar
• SmalleyWERayWADaughertyJRGriffinMRNonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly personsAm J Epidemiol199514165395457900721
   PubMed Web of Science ®Google Scholar
• SandlerRSEverhartJEDonowitzMThe burden of selected digestive diseases in the United StatesGastroenterology200212251500151111984534
   PubMed Web of Science ®Google Scholar
• SaadRCheyWDA clinician’s guide to managing Helicobacter pylori infectionCleve Clin J Med2005722109110112113117118 passim15757167
   PubMed Web of Science ®Google Scholar
• FendrickAMScheimanJMHelicobacter pylori and NSAID gastropathy: an ambiguous associationCurr Rheumatol Rep20013210711111286665
   PubMedGoogle Scholar
• GabrielSEJaakkimainenLBombardierCRisk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysisAnn Intern Med1991115107877961834002
   PubMed Web of Science ®Google Scholar
• GoldsteinJLLowrySCLanzaFLSchwartzHIDodgeWEThe impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitorAliment Pharmacol Ther200623101489149816669964
   PubMed Web of Science ®Google Scholar
• NivYBattlerAAbuksisGGalESapoznikovBVilkinAEndoscopy in asymptomatic minidose aspirin consumersDig Dis Sci2005501788015712641
   PubMed Web of Science ®Google Scholar
• YeomansNDLanasAITalleyNJPrevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirinAliment Pharmacol Ther200522979580116225488
   PubMed Web of Science ®Google Scholar
• Hernandez-DiazSGarcia RodriguezLACardioprotective aspirin users and their excess risk of upper gastrointestinal complicationsBMC Med200642216987411
   PubMed Web of Science ®Google Scholar
• MoukarbelGVSignorovitchJEPfefferMAGastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT TrialEur Heart J200930182226223219556260
   PubMed Web of Science ®Google Scholar
• HirataYKataokaHShimuraTIncidence of gastrointestinal bleeding in patients with cardiovascular disease: buffered aspirin versus enteric-coated aspirinScand J Gastroenterol2011467–880380921501103
   PubMed Web of Science ®Google Scholar
• RamakrishnanKSalinasRCPeptic ulcer diseaseAm Fam Physician20077671005101217956071
   PubMed Web of Science ®Google Scholar
• EisenGMDominitzJAFaigelDOAn annotated algorithmic approach to upper gastrointestinal bleedingGastrointest Endosc200153785385811375617
   PubMed Web of Science ®Google Scholar
• AbrahamNSEl-SeragHBJohnsonMLNational adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugsGastroenterology200512941171117816230071
   PubMed Web of Science ®Google Scholar
• HennekensCHSechenovaOHollarDSerebruanyVLDose of aspirin in the treatment and prevention of cardiovascular disease: current and future directionsJ Cardiovasc Pharmacol Ther200611317017617056829
   PubMed Web of Science ®Google Scholar
• ValkhoffVESturkenboomMCKuipersEJRisk factors for gastrointestinal bleeding associated with low-dose aspirinBest Pract Res Clin Gastroenterol201226212514022542151
   PubMed Web of Science ®Google Scholar
• BhattDLScheimanJAbrahamNSACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus DocumentsCirculation2008118181894190918836135
   PubMed Web of Science ®Google Scholar
• Antithrombotic Trialists CollaborationCollaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ20023247329718611786451
   PubMed Web of Science ®Google Scholar
• PignoneMAlbertsMJColwellJAAspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology FoundationCirculation2010121242694270120508178
   PubMed Web of Science ®Google Scholar
• LichtenbergerLMPhanTOkabeSAspirin’s ability to induce intestinal injury in rats is dependent on bile and can be reversed if pre-associated with phosphatidylcholineJ Physiol Pharmacol201162449149622100851
   PubMed Web of Science ®Google Scholar
• ChanFKAnti-platelet therapy and managing ulcer riskJ Gastroenterol Hepatol201227219519922142030
   PubMed Web of Science ®Google Scholar
• TamuraAMurakamiKKadotaJOITA-GF Study InvestigatorsPrevalence and independent factors for gastroduodenal ulcers/erosions in asymptomatic patients taking low-dose aspirin and gastroprotective agents: the OITA-GF studyQJM2011104213313920870780
   PubMed Web of Science ®Google Scholar
• HuangJQSridharSHuntRHRole of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysisLancet20023599300142211809181
   PubMed Web of Science ®Google Scholar
• HawthorneABMahidaYRColeATHawkeyCJAspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesisBr J Clin Pharmacol199132177831888645
   PubMed Web of Science ®Google Scholar
• HawkeyCJReview article: aspirin and gastrointestinal bleedingAliment Pharmacol Ther1994821411468038346
   PubMed Web of Science ®Google Scholar
• CryerBBhattDLLanzaFLDongJFLichtenbergerLMMarathiUKLow-dose aspirin-induced ulceration is attenuated by aspirin-phosphatidylcholine: a randomized clinical trialAm J Gastroenterol2011106227227721081908
   PubMed Web of Science ®Google Scholar
• LettinoMInhibition of the antithrombotic effects of clopidogrel by proton pump inhibitors: facts or fancies?Eur J Intern Med201021648448921111931
   PubMed Web of Science ®Google Scholar
• LichtenbergerLMWhere is the evidence that cyclooxygenase inhibition is the primary cause of nonsteroidal anti-inflammatory drug (NSAID)-induced gastrointestinal injury? Topical injury revisitedBiochem Pharmacol200161663163711266647
   PubMed Web of Science ®Google Scholar
• LanasAScheimanJLow-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatmentCurr Med Res Opin200723116317317257477
   PubMed Web of Science ®Google Scholar
• Cea SorianoLRodriguezLARisk of upper gastrointestinal bleeding in a cohort of new users of low-dose ASA for secondary prevention of cardiovascular outcomesFront Pharmacol2010112621811460
   PubMed Web of Science ®Google Scholar
• LanasAFuentesJBenitoRSerranoPBajadorESainzRHelicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirinAliment Pharmacol Ther200216477978611929396
   PubMed Web of Science ®Google Scholar
• NgWWongWMChenWHIncidence and predictors of upper gastrointestinal bleeding in patients receiving low-dose aspirin for secondary prevention of cardiovascular events in patients with coronary artery diseaseWorld J Gastroenterol200612182923292716718820
   PubMed Web of Science ®Google Scholar
• OkadaKInamoriMImajoKClinical study of upper gastrointestinal bleeding associated with low-dose aspirin in Japanese patientsHepatogastroenterology200956961665166920214214
   PubMedGoogle Scholar
• SerranoPLanasAArroyoMTFerreiraIJRisk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseasesAliment Pharmacol Ther200216111945195312390104
   PubMed Web of Science ®Google Scholar
• LanasABajadorESerranoPNitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleedingN Engl J Med20003431283483910995862
   PubMed Web of Science ®Google Scholar
• de AbajoFJGarcia RodriguezLARisk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulationsBMC Clin Pharmacol20011111228592
   PubMedGoogle Scholar
• LanasAGarcia-RodriguezLAArroyoMTRisk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinationsGut200655121731173816687434
   PubMed Web of Science ®Google Scholar
• WeilJColin-JonesDLangmanMProphylactic aspirin and risk of peptic ulcer bleedingBMJ199531069838278307711618
   PubMed Web of Science ®Google Scholar
• UddMMiettinenPPalmuAAnalysis of the risk factors and their combinations in acute gastroduodenal ulcer bleeding: a case-control studyScand J Gastroenterol200742121395140317994466
   PubMed Web of Science ®Google Scholar
• SostresCGargalloCJArroyoMTLanasAAdverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tractBest Pract Res Clin Gastroenterol201024212113220227026
   PubMed Web of Science ®Google Scholar
• ZulloAHassanCOlivetiDHelicobacter pylori management in non-steroidal anti-inflammatory drug therapy patients in primary careIntern Emerg Med20127433133521451987
   PubMed Web of Science ®Google Scholar
• AntmanEMAnbeDTArmstrongPWACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction – executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction)Circulation2004110558863615289388
   PubMed Web of Science ®Google Scholar
• Writing Committee MembersJneidHAndersonJLWrightWS2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/Non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelinesCirculation2012126787591022800849
   PubMed Web of Science ®Google Scholar
• WannLSCurtisABJanuaryCT2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuidelinesJ Am Coll Cardiol201157222324221177058
   PubMed Web of Science ®Google Scholar
• BhattDLScheimanJAbrahamNSACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus DocumentsJ Am Coll Cardiol200852181502151719017521
   PubMed Web of Science ®Google Scholar
• RubboliAHalperinJLPro: ‘Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions’Thromb Haemost2008100575275318989515
   PubMed Web of Science ®Google Scholar
• [No authors listed]Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study groupLancet199634790015615688596317
   PubMed Web of Science ®Google Scholar
• AndreottiFTestaLBiondi-ZoccaiGGCreaFAspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patientsEur Heart J200627551952616143706
   PubMed Web of Science ®Google Scholar
• CollinsRMacMahonSFlatherMClinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trialsBMJ199631370586526598811758
   PubMed Web of Science ®Google Scholar
• YusufSMehtaSRXieCEffects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevationJAMA2005293442743515671427
   PubMed Web of Science ®Google Scholar
• PaikinJSWrightDSCrowtherMAMehtaSREikelboomJWTriple antithrombotic therapy in patients with atrial fibrillation and coronary artery stentsCirculation2010121182067207020458022
   PubMed Web of Science ®Google Scholar
• BureslyKEisenbergMJZhangXPiloteLBleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarctionArch Intern Med2005165778478915824298
   PubMedGoogle Scholar
• GilardMBlanchardDHelftGAntiplatelet therapy in patients with anticoagulants undergoing percutaneous coronary stenting (from STENTIng and oral antiCOagulants [STENTICO])Am J Cardiol2009104333834219616664
   PubMed Web of Science ®Google Scholar
• MattichakSJReedPSGallagherMJBouraJAO’NeillWWKahnJKEvaluation of safety of warfarin in combination with antiplatelet therapy for patients treated with coronary stents for acute myocardial infarctionJ Interv Cardiol200518316316615966919
   PubMedGoogle Scholar
• OrfordJLFasseasPMelbySSafety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulationAm Heart J2004147346346714999195
   PubMed Web of Science ®Google Scholar
• Ruiz-NodarJMMarinFHurtadoJAAnticoagulant and anti-platelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosisJ Am Coll Cardiol200851881882518294566
   PubMed Web of Science ®Google Scholar
• RubboliAHalperinJLAiraksinenKEAntithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillationAnn Med200840642843618608125
   PubMed Web of Science ®Google Scholar
• SchomigASarafoffNSeyfarthMTriple antithrombotic management after stent implantation: when and how?Heart200995151280128519605755
   PubMed Web of Science ®Google Scholar
• FaxonDPEikelboomJWBergerPBAntithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summaryCirc Cardiovasc Interv20114552253422010191
   PubMed Web of Science ®Google Scholar
• BytzerPConnollySJYangSAnalysis of upper gastrointestinal adverse events among patients given dabigatran in the RE-LY trialClin Gastroenterol Hepatol2013113246252 e1–e523103906
   PubMed Web of Science ®Google Scholar
• NesselCCMahaffeyKWPicciniJPIncidence and outcomes of gastrointestinal hemorrhage in patients with atrial fibrillation treated with rivaroxaban or warfarin: results from the ROCKET AF trialChest2012142Suppl 484A
   Google Scholar
• Antithrombotic Trialists’ (ATT) CollaborationBaigentCBlackwellLCollinsRAspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsLancet200937396781849186019482214
   PubMed Web of Science ®Google Scholar
• SungJJLauJYChingJYContinuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trialAnn Intern Med201015211919949136
   PubMed Web of Science ®Google Scholar
• KellyJPKaufmanDWJurgelonJMSheehanJKoffRSShapiroSRisk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered productLancet19963489039141314168937281
   PubMed Web of Science ®Google Scholar
• LanzaFLRoyerGLJrNelsonRSEndoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosaN Engl J Med198030331361386966762
   PubMed Web of Science ®Google Scholar
• BurnessCBScottLJAcetylsalicylic acid/esomeprazole fixed-dose combinationDrugs Aging201229323324222372726
   PubMed Web of Science ®Google Scholar
• YeomansNLanasALabenzJEfficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirinAm J Gastroenterol2008103102465247318637091
   PubMed Web of Science ®Google Scholar
• ScheimanJMDevereauxPJHerlitzJPrevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON)Heart2011971079780221415072
   PubMed Web of Science ®Google Scholar
• TytgatGNLong-term consequences of Helicobacter pylori eradicationScand J Gastroenterol Suppl199420538447863240
   PubMedGoogle Scholar
• SabbiTShort review about Helicobacter pylori infection in pediatric age: epidemiological and clinical findings, diagnosis, therapy and role of probioticsPediatr Med Chir2011335–622122622428430
   PubMedGoogle Scholar
• ChanFKChungSCSuenBYPreventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxenN Engl J Med20013441396797311274623
   PubMed Web of Science ®Google Scholar
• LaiKCLamSKChuKMLansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin useN Engl J Med2002346262033203812087138
   PubMed Web of Science ®Google Scholar
• ChanFKChingJSuneBYEffect of H. pylori eradication on the long-term incidence of recurrent ulcer bleeding in high-risk aspirin users: a 10-year prospective cohort studyGastroenterology2011140173174
   Web of Science ®Google Scholar
• GeorgeMGTongXSonnenfeldNRecommended use of aspirin and other antiplatelet medications among adults – National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey, United States, 2005–2008MMWR Surveill Summ20126121118
   Google Scholar
• FendrickAForschRHarrisonRScheimanJPeptic ulcer diseaseUniversity of Michigan Health System Guidelines for Clinical Care200517 Available from: http://www.med.umich.edu/1info/fhp/practiceguides/newpud/pud.pdf
   Google Scholar
• JoneGMorrealeACost-benefit computer modeling of Helicobacter pylori testing and treatment in patients on long-term H2-blocker prophylaxisJ Managed Care Pharm200065383389
   Google Scholar
• HennekensCHIncreasing burden of cardiovascular disease: current knowledge and future directions for research on risk factorsCirculation19989711109511029531257
   PubMed Web of Science ®Google Scholar
• Antiplatelet Trialists’ CollaborationCollaborative overview of randomised trials of antiplatelet therapy-III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patientsBMJ199430869232352468054013
   PubMed Web of Science ®Google Scholar
• US Preventive Services Task ForceAspirin for the prevention of cardiovascular disease: US Preventive Services Task Force recommendation statementAnn Intern Med2009150639640419293072
   PubMed Web of Science ®Google Scholar
• O’GradyNPAlexanderMDellingerEPGuidelines for the prevention of intravascular catheter-related infectionsAm J Infect Control200230847648912461511
   PubMed Web of Science ®Google Scholar
• British Cardiac Society, British Hypertension Society, Diabetes UK, Heart UK, Primary Care Cardiovascular Society, Stroke AssociationJBS 2: Joint British Societies’ guidelines on prevention of cardiovascular disease in clinical practiceHeart200591Suppl 5v1v5216365341
   PubMed Web of Science ®Google Scholar
• LanzaFLChanFKQuigleyEMPractice Parameters Committee of the American College of GasreoenterologyGuidelines for prevention of NSAID-related ulcer complicationsAm J Gastroenterol2009104372873819240698
   PubMed Web of Science ®Google Scholar
• QuinlanDJEikelboomJWGoodmanSGImplications of variability in definition and reporting of major bleeding in randomized trials of oral P2Y12 inhibitors for acute coronary syndromesEur Heart J201132182256226521624900
   PubMed Web of Science ®Google Scholar